Letrozole and ribociclib and Moxetumomab pasudotox
Determining the interaction of Letrozole and ribociclib and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letrozole and ribociclib-Moxetumomab Pasudotox-tdfk
- Letrozole and ribociclib-Moxetumomab pasudotox-tdfk Intravenous
- Letrozole and ribociclib-Moxifloxacin
- Letrozole and ribociclib-Moxifloxacin (Systemic)
- Letrozole and ribociclib-Moxifloxacin Hydrochloride
- Letrozole and ribociclib-Moxifloxacin Injection
- Moxetumomab pasudotox-Leucovorin
- Moxetumomab pasudotox-Leucovorin Calcium
- Moxetumomab pasudotox-Leucovorin injection
- Moxetumomab pasudotox-Leucovorin Oral, Intravenous, Injection
- Moxetumomab pasudotox-Leucovorin Tablets
- Moxetumomab pasudotox-Leukeran